Funder
National Natural Science Foundation of China
Natural Science Foundation of Shandong Province
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference41 articles.
1. Cancer immunoediting and resistance to T cell-based immunotherapy;O’Donnell;Nat. Rev. Clin. Oncol.,2018
2. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma;Schadendorf;J. Clin. Oncol.,2015
3. Overall survival with combined nivolumab and ipilimumab in advanced melanoma;Wolchok;N. Engl. J. Med.,2017
4. Multi-phenotype CRISPR-Cas9 Screen Identifies p38 kinase as a target for adoptive immunotherapies;Gurusamy;Cancer Cell,2020
5. A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells;Singer;Cell,2016
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献